Ticker
VIVSCompany Name
VIVOSIM LABS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 4.56M | $ 4.41M | $ 0 | -96.69% |
3/31/2025 | $ 4.77M | $ 8.85M | $ 0 | -185.45% |
12/31/2024 | $ 6.58M | $ 5.93M | $ 0 | -90.06% |
9/30/2024 | $ 6.17M | $ 7.32M | $ 0 | -118.54% |
6/30/2024 | $ 8.25M | $ 7.69M | $ 0 | -93.19% |
3/31/2024 | $ 14.13M | $ 1.44M | $ 0 | -10.17% |
12/31/2023 | $ 10.04M | $ 1.17M | $ 0 | -11.68% |
9/30/2023 | $ 12.9M | $ 0 | $ 0 | 0% |
6/30/2023 | $ 13.86M | $ 0 | $ 0 | 0% |
3/31/2023 | $ 15.08M | $ 0 | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for VIVOSIM LABS INC is calculated as follows: (-1 * CF - Equity [ $ 13K ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 69.74M ]
(=) Payout Yield [ -0.02% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2022
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |